Literature DB >> 8049554

A case of pemphigus foliaceus after interferon alpha-2a therapy.

H Niizeki1, N Inamoto, K Nakamura, K Tsuchimoto, T Hashimoto, T Nishikawa.   

Abstract

We present here a 63-year-old man with chronic hepatitis C who developed bullous lesions and anti-intercellular antibodies when he received interferon (IFN) alpha-2a, 9 MU subcutaneously, 3 times a week for 3 months. The direct immunofluorescence was consistent with pemphigus features. The indirect immunofluorescence showed negative before IFN treatment, but it became positive after 3 months. The immunoblot study showed no specific bands. This is the third report of the bullous lesions with anti-intercellular antibodies following IFN therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049554     DOI: 10.1159/000246954

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

Review 1.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

3.  High levels of interleukin-1 in patients with endemic pemphigus foliaceus.

Authors:  Denise Bertulucci Rocha-Rodrigues; Giovana Paschoini; Sanivia Aparecida Lima Pereira; Marlene Antonia dos Reis; Vicente de Paula Antunes Teixeira; Virmondes Rodrigues Júnior
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 4.  Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.

Authors:  M Haria; P Benfield
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

5.  Possible Role for Plasmacytoid Dendritic Cells in Pemphigus.

Authors:  Nehmat Ramadan; Mazen Kurban; Ossama Abbas
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.